These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10698053)

  • 1. Obesity and hypertension.
    Faloia E; Giacchetti G; Mantero F
    J Endocrinol Invest; 2000 Jan; 23(1):54-62. PubMed ID: 10698053
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity and hypertension.
    El-Atat F; Aneja A; Mcfarlane S; Sowers J
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):823-54. PubMed ID: 14711064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    De Boer MP; Meijer RI; Wijnstok NJ; Jonk AM; Houben AJ; Stehouwer CD; Smulders YM; Eringa EC; Serné EH
    Microcirculation; 2012 Jan; 19(1):5-18. PubMed ID: 21883642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in mechanisms of obesity-induced hypertension: role of adipose tissue.
    Sharma AM; Engeli S; Pischon T
    Curr Hypertens Rep; 2001 Apr; 3(2):152-6. PubMed ID: 11276398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obesity and hypertension. Recent advances in etiopathogenesis].
    Cesareo R; Iozzino M; Napolitano C; De Rosa P; De Rosa B; Orsini A
    Recenti Prog Med; 2007; 98(7-8):398-400. PubMed ID: 17685189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of obesity-related hypertension.
    Lamounier-Zepter V; Bornstein SR; Ehrhart-Bornstein M
    Horm Metab Res; 2004 Jun; 36(6):376-80. PubMed ID: 15241727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and hypertension: a review.
    Imam K; Sowers JR
    Henry Ford Hosp Med J; 1988; 36(2):82-7. PubMed ID: 3068210
    [No Abstract]   [Full Text] [Related]  

  • 8. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal aspects of the pathogenesis of arterial hypertension in young obese patients].
    Tereshchenko IV; Vladimirskaia NL
    Probl Endokrinol (Mosk); 1993; 39(5):26-8. PubMed ID: 8108342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue.
    Aghamohammadzadeh R; Heagerty AM
    Ann Med; 2012 Jun; 44 Suppl 1():S74-84. PubMed ID: 22713152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-related hypertension and the insulin resistance syndrome.
    Landsberg L
    Trans Am Clin Climatol Assoc; 1995; 106():69-75; discussion 75-6. PubMed ID: 7483180
    [No Abstract]   [Full Text] [Related]  

  • 12. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
    Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal obesity and risk.
    Björntorp P
    Clin Exp Hypertens A; 1990; 12(5):783-94. PubMed ID: 2208750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Obesity and hypertension: from physiopathology to treatment].
    Geronooz I; Krzesinski JM
    Rev Med Liege; 2000 Oct; 55(10):921-8. PubMed ID: 11244800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocytokines in relation to cardiovascular disease.
    Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
    Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging biology of adipose tissue in chronic kidney disease: from fat to facts.
    Axelsson J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3041-6. PubMed ID: 18632589
    [No Abstract]   [Full Text] [Related]  

  • 17. European Society of Hypertension Working Group on Obesity: background, aims and perspectives.
    Jordan J; Engeli S; Redon J; Sharma AM; Luft FC; Narkiewicz K; Grassi G;
    J Hypertens; 2007 Apr; 25(4):897-900. PubMed ID: 17351387
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypertension in obese patients: Pathophysiology and management].
    Girerd X; Hansel B
    Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, hypertension, and the heart.
    Good D; Morse SA; Ventura HO; Reisin E
    J Cardiometab Syndr; 2008; 3(3):168-72. PubMed ID: 18983334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysmetabolic symptomatic arterial hypertension and dysmetabolic disease].
    Bokarev IN; Shubina OI
    Klin Med (Mosk); 2009; 87(8):67-71. PubMed ID: 19827536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.